More on HXBM
Data
Financials
News
Click line-items for a historical chart and %
| Licensing fees | |
| Peptide and consumer product sales | |
| Consumer product sales, related party | |
| Total revenue | |
| Cost of peptide and consumer product sales | |
| Cost of consumer product sales, related party | |
| Total cost of revenue | |
| Gross profit | |
| Research and development | |
| Marketing and business development | |
| General and administrative | |
| Accounting, legal and professional fees | |
| Depreciation and amortization | |
| Total operating expenses | -1.08M |
| Loss from operations | |
| Interest income | |
| Interest expense on convertible notes payable | |
| Interest expense on convertible notes payable, related party | |
| Accretion of discount on convertible notes payable | |
| Accretion of discount on convertible notes payable, related party | |
| Equity in loss of affiliated company | |
| Change in fair value of option to purchase interest in affiliated company | |
| Total other income (expense), net | |
| Net loss and comprehensive loss | |
| Basic and diluted net loss per share (in Dollars per share) | |
| Weighted average shares outstanding (in Shares) | |
